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Abstract To evaluate ozone damage to hairless mouse skin, two 
parameters of oxidative damage, vitamin E depletion and 
malondialdehyde (MDA) production, were measured in vitamin 
E-enriched and in control skin from mice exposed to ozone (10 
ppm). A 5% vitamin E solution (tocotrienol-rich fraction, TRF) 
in polyethylene glycol (PEG) was applied to 2 sites on the back 
of hairless mice, PEG to 2 sites. After 2 h, the sites were washed, 
one of each pair of sites covered and the mice exposed ozone for 
2 h. Ozone exposure (compared with covered sites) increased 
epidermal MDA in PEG-treated sites, while vitamin E was 
unchanged. In contrast, ozone exposure significantly depleted 
vitamin E in TRF-treated sites, while significant MDA 
accumulation was prevented. This is the first demonstration that 
ozone exposure causes damage to cutaneous lipids, an effect 
which can be attenuated by vitamin E application. 
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1. Introduction 
Ozone is the major air pollutant in photochemical smog. 
Since half the US population lives in areas exceeding the US 
National Ambient Air Quality Standard (0.12 ppm averaged 
over a 1 h period) [1], the presence of ozone in the air poses 
significant concern [2]. 
Ozone exposure causes oxidation and peroxidation of bio-
molecules both directly and/or via secondary products of 
ozone reactions [3-8]. One of the most important mechanisms 
of ozone injury is peroxidation of lipids, especially unsatu-
rated fatty acids [5,7,8]; in vitro, vitamin E appears to prevent 
the propagation of this reaction [6]. Although cc-tocopherol 
has the highest biologic activity of the various vitamin E iso-
mers [9], the properties of some of the other isomers suggest 
that they might be more protective against ozone-induced 
damage. For example, a-tocotrienol has a higher antioxida-
tive activity than oc-tocopherol against Fe2+/ascorbate and 
Fe2+/NADPH-induced lipid peroxidation in rat liver micro-
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somes [10]. Alternatively, ozone might attack the chromanol 
nucleus of γ-tocotrienol or γ-tocopherol in an analogous man-
ner to that described for nitrogen dioxide [11]. 
Skin is the organ the most directly exposed to ozone. In 
fact, ozone is probably the most reactive environmental pol-
lutant to which skin is routinely exposed. Unlike the lung [4], 
very little attention has been paid to the potential effects of 
environmental oxidant pollutants on cutaneous tissues. This is 
somewhat surprising since skin contains peroxidizable lipids 
and these constituents are in part responsible for the cuta-
neous permeability barrier [12]. 
A variety of enzymatic and non-enzymatic antioxidants 
protect skin against oxidative stress [13-17]. Among these is 
vitamin E. Of the vitamin E isomers, skin α-tocopherol con-
centrations are much higher than γ-tocopherol or a- and γ-
tocotrienols [18]. However, skin can be enriched by topical 
application of these vitamin E isomers [19]. 
This study tested the hypotheses that (1) ozone attacks skin 
lipids and lipophilic antioxidants and (2) topical application 
of a mixture of vitamin E forms, including tocopherols and 
tocotrienols from a tocotrienol-rich palm oil fraction (TRF), 
ameliorates this oxidative damage. 
2. Materials and methods 
2.1. Chemicals 
All chemicals used were of the highest grade available. Tocopherol 
standards were provided by Henkel Corporation (LaGrange, IL). 
TRF was kindly provided by PORIM (Kuala Lumpur, Malaysia). 
Tocotrienols for use as standards were purified from TRF by Dr. 
Asaf A. Qureshi, University of Wisconsin (Madison, WI). TRF vita-
min E are extracted from palm oil and so are in the 'natural' config-
uration - both a- and γ-tocopherols have 2R, 4'R, 8'R-stereochem-
istry; both ot- and γ-tocotrienols have 2R stereochemistry. 
2.2. Animals 
Animal care, handling, and experimental procedures were carried 
out as described in the animal use protocol approved by the Animal 
Care and Use Committee of the University of California, Berkeley, 
CA. Hairless mice (females, between 8 and 10 weeks old, Charles 
River Laboratories, Wilmington, MA, USA) were housed under 
standard light and temperature conditions. Food (Harlan Tecklad 
Rodent Diet #1846, Madison, WI, USA) and water were provided 
ad libitum. Mice were anesthetized by an intraperitoneal injection of 
sodium pentobarbital (50 mg/kg body weight, Nembutal, Abbott 
Laboratories, North Chicago, IL) and remained anesthetized during 
the entire experimental period. 
2.3. Vitamin E application 
A 5% w/v solution of TRF was prepared in polyethylene glycol-400 
(PEG; Sigma, St. Louis, MO). Mice were anesthetized, then 4 poly-
propylene plastic rings (1 cm2) were glued onto the animals' backs, 
subsequently TRF solution (20 μΐ) was applied to 2 rings and PEG to 
the other 2 rings. After 2 h, the treated areas were washed as de-
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scribed by Dupuis et al. [20]. Briefly, the skin was rinsed 3 times with 
300 μΐ ethanol:water (95:5), then twice with water alone and dried 
with a cotton tip. After washing, the location of the application site 
was marked and the plastic rings removed; half of the sites were 
covered with a piece of Kimwipe tissue (Kimberly Clarke, Atlanta, 
GA) and sealed with cellophane tape. The Kimwipe prevented injury 
to the skin during the removal of the adhesive tape following exposure 
to either air (n = 3, control) or ozone (n = 4) (see below). 
2.4. Ozone exposure 
Ozone was produced from oxygen by electric discharge (Sander 
ozonizer model IV, Eltze, Germany). The ozone was then mixed 
with filtered (ozone-free) ambient air and allowed to flow into a stain-
less steel exposure chamber at a constant rate (200 1/min). The con-
centration in the exposure chamber was adjusted to 10 ppm and 
continuously monitored with an ozone analyzer (Dasibi model 1003-
AH, Glendale, CA). The ozone chamber provided a maximum space 
for 4 animals during the 2 h ozone exposure. Control mice were 
treated identically in terms of anesthesia and animal handling, but 
were kept under air (0 ppm ozone). 
After air or ozone exposure, the mice were given another dose of 
pentobarbital, allowed to rest for 30 min, then were killed by cervical 
dislocation. The skin was excised, the subcutaneous fat removed with 
a scalpel, then punch biopsies were taken and the samples immedi-
ately frozen in liquid nitrogen. The skin samples were stored for no 
longer than a week at —80°C. 
2.5. Vitamin E analysis 
Tocopherols and tocotrienols were extracted from full thickness 
skin, as described [21,22]. Briefly, the skin sample was weighed (ap-
proximately 20 mg), ground under liquid nitrogen, then homogenized 
in a Potter-Elvehjem homogenizing tube with 2 ml buffer (10 mM 
phosphate, 130 mM NaCl, 1 mM EDTA, pH 7.0) and 50 ml BHT 
(1 mg/ml) and extracted after addition of 1 ml of 0.1 M SDS, 2 ml 
ethanol and 2 ml hexane. An appropriate aliquot of hexane was used 
for HPLC analysis, as described [23]. The electrochemical detector 
was operated with a 0.5 V potential, full recorder scale at 50 nA 
for quantitation of a- and γ-tocopherols and a- and γ-tocotrienols. 
Authentic compounds were used to generate standard curves. 
2.6. Lipidperoxidation 
Fluorimetric detection of the malondialdehyde-thiobarbituric acid 
adduct (MDA-TBA) was performed after HPLC separation of the 
TBA-reactive substances, based on methods for MDA determination 
in plasma and other body tissues [19-21]. After weighing, the scraped 
mouse epidermis was extracted with 2 ml methanol, 2 ml 15% SDS 
solution, 50 μΐ 10% BHT in ethanol and 4 ml chloroform. An aliquot 
of the chloroform was dried and the residue resuspended in 400 μΐ 
15% SDS and incubated with 250 μΐ 0.375% TBA and 200 μΐ 1.22 M 
phosphoric acid for 30 min at 100°C, followed by addition of 380 μΐ 
methanol and 20 μΐ 1 N NaOH. After centrifugation, 100 μΐ super-
natant were injected into the HPLC system, which consisted of a 114 
M Solvent Delivery Module pump (Beckman, Fullerton, CA), an 
Alltima C18 column and a Hitachi (Hitachi Ltd. Tokyo, Japan) F-
105 fluorescence spectrophotometer (excitation 532 nm and emission 
553 nm). The mobile phase consisted of 60% methanol and 40% 50 
mM NaH2P04, pH adjusted to 5.5, at a rate of 0.9 ml/min. MDA 
standards (ranging from 0.5 to 10 pmol) were prepared using dilutions 
of 1,1,3,3-tetramethoxypropane. Samples and standards were ana-
lyzed in duplicate. 
2.7. Statistical analysis 
All statistical analyses were carried out using SuperAnova (Abacus 
Concepts, Inc., Berkeley, CA) for the Macintosh (Apple Computers, 
Cupertino, CA). Analyses included: one-factor ANOVA (air vs. 
ozone); two-factor ANOVA with 2 within groups repeated measures 
(PEG vs. TRF, and covered vs. exposed) with least square means 
comparisons. Data were log-transformed to equalize variances be-
tween TRF- and PEG-treated sites. A P-value < 0.05 was considered 
statistically significant. Values are given as means ± S.D. 
3. Results 
3.1. Antioxidants in murine skin 
To investigate the susceptibility of skin to ozone damage, a 
study design was planned using covered and uncovered skin 
sites, such that each animal would serve as its own control. 
Therefore, we first evaluated whether covering the skin 
changed the antioxidant composition. PEG was applied to 2 
sites and TRF to 2 sites, the compounds were allowed to 
penetrate for 2 h, then the skin was washed. Subsequently, 
half of the sites were covered with tissue paper and sealed with 
cellophane tape for 2 h during which time the mice were ex-
posed to air. Tocopherols and tocotrienols in PEG-treated air-
exposed skin were within the range of previous reports from 
our laboratory [19,24], while covering the skin significantly 
increased vitamin E contents (Table 1). TRF treatment re-
sulted in significant increases in the concentrations of all vi-
tamin E forms, as reported previously [19]. However, covering 
the TRF-treated sites resulted in significantly lower concentra-
tions of vitamin E than in the uncovered sites. 
To evaluate whether the various vitamin E forms pene-
trated murine skin differently, the percentage distribution of 
each of the vitamin E homologues in the TRF suspension was 
compared to its percentage distribution in skin treated with 
TRF or vehicle (PEG) alone (Fig. 1). The percentage distribu-
tion of vitamin E forms that penetrated the skin (above back-
ground concentrations) was significantly different from their 
distribution in the TRF suspension - a higher percentage of 
α-tocopherol was found in TRF-treated skin than was present 
in TRF suspension (P<0.01). 
3.2. Ozone exposure depletes vitamin E-enriched skin 
To evaluate skin damage caused by ozone, vitamin E con-
centrations were used as a marker of oxidative damage. The 
concentrations of the various vitamin E isomers were meas-
ured in the 4 sites (PEG-treated covered and uncovered, 
TRF-treated covered and uncovered) in mice exposed to 
ozone (10 ppm for 2 h) (Fig. 2). Surprisingly ozone had no 
measurable effect on the inherent vitamin E concentrations 
measured in whole thickness skin. The vitamin E contents 
of sites from ozone-exposed PEG-treated covered and uncov-
ered were similar (Fig. 2), and these values were similar to 
those in air-exposed PEG-treated, mice (Table 1). Thus, ozone 
exposure did not deplete inherent skin vitamin E. 
By contrast to inherent vitamin E, skin with topically ap-
plied vitamin E was readily susceptible to ozone damage (Fig. 
2). Ozone exposure significantly depleted TRF-treated skin 
vitamin E: ot-tocopherol (P<0.01), γ-tocopherol (P<0.05), 
α-tocotrienol (P<0.05) and γ-tocotrienol (P<0.04). None-
Table 1 
Vitamin E contents (pmol/mg skin) of murine skin following topical application of PEG or TRF, then covered or exposed to air 
Applied Treatment a-Tocopherol γ-Tocopherol a-Tocotrienol γ-Tocotrienol 
5.6 ±2.5 
2.5 ±1.3 
39.5 ±26.5 
109.4 ±74.7 
PEG 
PEG 
TRF 
TRF 
Covered 
Exposed 
Covered 
Exposed 
29±4 
15±3 
138 ±64 
357 ±210 
2.3 ±0.3 
0.5 ±0.2 
17.1 ±8.6 
44.8 ±28.3 
6.4± 1.1 
2.1 ±0.8 
45.0±21.7 
113.7±73.0 
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Fig. 1. Vitamin E distribution. The percent of each of the vitamin E 
forms found in PEG-treated skin, in TRF-treated skin and in the 
TRF suspension are shown. The TRF-treated skin contained a sig-
nificantly higher percentage of α-tocopherol (P<0.01) than did the 
applied TRF. 
theless, after ozone exposure, the concentrations of all vitamin 
E forms were the same (γ-tocotrienol, P<0.06), or signifi-
cantly higher in the TRF-treated ozone exposed-skin than in 
the PEG-treated, covered-skin (a-tocopherol: P<0.02, γ-to-
copherol: P<0.04 , a-tocotrienol: P<0.04) . 
Covering the skin during ozone exposure prevented vitamin 
E depletion in the TRF-treated sites. The ozone-exposed, cov-
ered TRF-treated sites (Fig. 2) contained similar vitamin E 
concentrations to those exposed to air (Table 1). Thus, the 
2 h ozone exposure, did not result in systemic effects that 
altered skin vitamin E concentrations. 
by ozone exposure and was reduced in TRF-treated skin. 
Analyses of antioxidant contents of uppermost skin layers 
(e.g. epidermis, stratum corneum) may be necessary to ob-
serve ozone-induced antioxidant depletion in cutaneous tis-
sues. 
Environmental ozone toxicity may result from the effects of 
a cascade of products that are produced in the reactions of 
ozone with primary target molecules that lie close to the air/ 
tissue boundary. These products, which have a lower reactiv-
ity and longer lifetime than ozone itself, can transmit the 
effects of ozone beyond the air/tissue interface [8,25]. To in-
vestigate whether the observed changes in vitamin E concen-
trations could, besides direct ozone effects to the skin, be due 
to effects of secondary products of ozone formed in the lung 
and brought to the dermis via blood circulation, one site of 
the mouse's back skin was covered by tape during ozone ex-
posure. Since no significant changes in vitamin E concentra-
tions were observed compared with air treatment (compare 
Fig. 1 with Table 1), we conclude that the observed antiox-
idant depletion in skin is primarily due to direct ozone effects 
to the skin. Furthermore, the high concentrations of plasma 
antioxidants [26] make it unlikely that significant amounts of 
secondary ozone products were transmitted from the respira-
tory tract to the skin via the dermal circulation during the 
short experimental period. 
The use of covered skin allowed animals to serve as their 
own controls during ozone exposure. However, the covered 
PEG-treated skin contained higher vitamin E concentrations 
than air-exposed skin, while the covered TRF-treated skin 
3.3. Oxidative damage to skin lipids 
To evaluate ozone damage to skin lipids, MDA was meas-
ured in the epidermal layers of skin from the 4 sites (PEG-
treated covered and uncovered, TRF-treated covered and un-
covered) in mice exposed to ozone (10 ppm for 2 h). Here a 
dramatic increase (P < 0.01) in the epidermal MDA of ozone-
exposed PEG-treated skin was observed (Fig. 3). The smaller 
increase in MDA observed in the ozone-exposed TRF-treated 
site was not statistically significant. These data suggest that 
ozone can oxidize the lipids present in the upper layers of skin 
and that to some degree this damage is ameliorated by applied 
vitamin E. 
4. Discussion 
Two major physiological implications arise from this study. 
(1) Ozone exposure (10 ppm for 2 h) causes lipid peroxidation 
in cutaneous tissues and (2) prior application of vitamin E can 
ameliorate some of the resultant oxidative damage. 
Although ozone exposure similarly depleted all the various 
forms of vitamin E (a-tocopherol, γ-tocopherol, a-tocotrienol, 
and γ-tocotrienol) that were applied topically, these forms in 
whole thickness skin were not significantly depleted. The ob-
servation that ozone depleted applied, but not inherent, vita-
min E suggests that ozone probably attacks the outermost 
layers of skin, where the applied forms of vitamin E are pre-
sumably the most concentrated. The supposition that ozone 
effects are primarily on the skin surface is further substan-
tiated by the observation that epidermal MDA was increased 
Fig. 2. Vitamin E content of murine skin after 2 h ozone exposure. 
The upper panels show the concentrations (mean ± S.D., n=4) of 
(A) α-tocopherol and (B) a-tocotrienol, γ-tocopherol, and γ-tocotrie-
nol in skin from covered or ozone-exposed sites after topical appli-
cation of PEG. The lower panels show the concentrations of (C) a-
tocopherol and (D) a-tocotrienol, γ-tocopherol, and γ-tocotrienol 
from covered or ozone-exposed sites after topical application of 
TRF. Significant decreases in each of the homologue concentrations 
were observed after ozone exposure in TRF-treated skin. By least 
square means comparisons: PEG-covered vs. PEG-exposed, NS. 
TRF-covered vs. TRF-exposed for α-tocopherol, P < 0.01; for a-to-
cotrienol, P<0.05; γ-tocopherol, P<0.05; and γ-tocotrienol, 
P<0.04. Covered sites PEG vs. TRF for α-tocopherol, P< 0.002; 
for a-tocotrienol, P<0.01; γ-tocopherol, P<0.01; and γ-tocotrie-
nol, P<0.01. 
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Fig. 3. MDA in murine skin. The MDA concentrations 
(mean ± S.D.) in mouse epidermis following application with PEG 
or TRF, covered or not, and exposed to ozone (n = 4). Only PEG 
treatment followed by ozone exposure significantly increased MDA 
(P<0.01). 
contained lower vitamin E concentrations than air-exposed 
skin (Table 1). The finding that covering the skin changed 
its antioxidant composition was unexpected. Most likely, cov-
ering the skin occluded it, increasing its moisture content, and 
changing its penetration characteristics [27]. Nonetheless, the 
skin vitamin E changes observed did not alter the conclusions 
of the study. 
The ozone concentration (10 ppm) used in this study, given 
for a longer exposure time, causes lethal damage to the res-
piratory system. In urban air pollution, lower ozone concen-
trations (0.1-0.8 ppm) are encountered [4]. Since no other 
data concerning cutaneous effects of ozone exposure are avail-
able, the present study was designed to assess responses to 
high levels of ozone exposure. Fur ther investigations are 
now needed to evaluate whether similar but less marked mo-
lecular skin damage takes place at lower, more relevant ozone 
concentrations and where this damage occurs. This most 
likely would require chronic or intermittent exposures and/ 
or more sensitive techniques to differentiate and analyze the 
uppermost epidermal skin layers, in particular the stratum 
corneum. 
In summary, the major finding of this study was that topi-
cally applied vitamin E forms are dramatically depleted by 
acute, short-term exposure to ozone. This is the first report 
showing that ozone is capable of initiating oxidative processes 
in cutaneous tissues. Whether ozone-related oxidative stress 
contributes to skin disorders as a result of lifetime exposure 
remains to be determined. 
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